Literature DB >> 8463133

Infrequent ras mutation in human stomach cancers.

M Koshiba1, O Ogawa, T Habuchi, S Hamazaki, T Shimada, R Takahashi, T Sugiyama.   

Abstract

Mutations of ras oncogenes in 37 human stomach cancers and 13 adenomas were investigated with regard to the histological phenotypes using polymerase chain reaction (PCR), allele-specific oligonucleotide hybridization and/or direct sequencing of the PCR products. The ras mutation was found only in one case (2.7%), the histology of which was poorly differentiated adenocarcinoma. We found no mutation in stomach adenomas. The mutation consisted of a guanine-to-adenine transition in the first base of codon 13 of c-Ki-ras which replaced wild-type glycine with serine, indicating that a putative glycine-to-aspartic acid change is not necessarily the critical event for c-Ki-ras gene activation in codon 13. These results further confirm the infrequency of ras mutation in stomach tumors and also suggest that ras mutations are not specific to the differentiated type of stomach cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8463133      PMCID: PMC5919135          DOI: 10.1111/j.1349-7006.1993.tb02850.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


polymerase chain reaction allele‐specific oligonucleotide sodium dodecyl sulfate
  22 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.

Authors:  T Victor; R Du Toit; A M Jordaan; A J Bester; P D van Helden
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

3.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues.

Authors:  M Koshiba; K Ogawa; S Hamazaki; T Sugiyama; O Ogawa; T Kitajima
Journal:  Pathol Res Pract       Date:  1993-02       Impact factor: 3.250

5.  Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.

Authors:  M C Hollstein; A M Smits; C Galiana; H Yamasaki; J L Bos; A Mandard; C Partensky; R Montesano
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

6.  Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

Authors:  J Yokota; T Yamamoto; N Miyajima; K Toyoshima; N Nomura; H Sakamoto; T Yoshida; M Terada; T Sugimura
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

7.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

8.  Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.

Authors:  M Fukumoto; R D Estensen; L Sha; G J Oakley; L B Twiggs; L L Adcock; L F Carson; I B Roninson
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

9.  Isolation of an amplified DNA sequence in stomach cancer.

Authors:  H Nakatani; H Sakamoto; T Yoshida; J Yokota; E Tahara; T Sugimura; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-08

10.  Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation.

Authors:  T Kihana; H Tsuda; T Hirota; Y Shimosato; H Sakamoto; M Terada; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1991-03
View more
  6 in total

1.  Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials.

Authors:  C Tsuchiya; S Ohshima; M Takahama
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

2.  A microRNA contribution to aberrant Ras activation in gastric cancer.

Authors:  Emily Ky Lam; Xian Wang; Vivian Y Shin; Shengjie Zhang; Helen Morrison; Jie Sun; Enders Ko Ng; Jun Yu; Hongchuan Jin
Journal:  Am J Transl Res       Date:  2011-02-06       Impact factor: 4.060

3.  Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations.

Authors:  S Sakurai; T Sano; A Maeshima; K Kashiwabara; T Oyama; T Fukuda; T Nakajima
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Frequent K-ras mutations in small bowel adenocarcinomas.

Authors:  T Sutter; N Arber; S F Moss; R I Findling; A I Neugut; I B Weinstein; P R Holt
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

5.  Rare occurrence of ras and p53 gene mutations in mouse stomach tumors induced by N-methyl-N-nitrosourea.

Authors:  C Furihata; M Tatematsu; M Saito; S Ishida; H Nakanishi; K Inada; H Tei; M Hattori; T Ito; Y Sakaki
Journal:  Jpn J Cancer Res       Date:  1997-04

6.  Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.

Authors:  S Inoue; A Nakao; Y Kasai; A Harada; T Nonami; H Takagi
Journal:  Jpn J Cancer Res       Date:  1995-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.